3S Pharmaceuticals India Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: 3S Pharmaceuticals India Private Limited Pharmaceutical Export Portfolio Dataset — 10 Products, $484.3K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

3S Pharmaceuticals India Private Limited — Pharmaceutical Exporter Profile (2026) | 10 Products, $484.3K Trade | TransData Nexus

3S Pharmaceuticals India Private Limited

Indian Pharmaceutical Exporter · Advanced Oncology Specialist · $484.3K Total Trade · DGFT Verified

3S Pharmaceuticals India Private Limited is an Indian pharmaceutical exporter with a total trade value of $484.3K across 10 products in 3 therapeutic categories. Based on 152 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Pembrolizumab ($201.7K), Lenalidomide ($88.4K), Daratumumab ($64.9K).

3S Pharmaceuticals India Private Limited — Export Portfolio & Destination Treemap

3S Pharmaceuticals India Private Limited pharmaceutical export portfolio — 10 products across 3 therapeutic categories. Source: Indian Customs (DGFT).

Who is 3S Pharmaceuticals India Private Limited? — Company Overview & Market Position

3S Pharmaceuticals India Private Limited is a private limited company incorporated on October 26, 2021, in Mumbai, Maharashtra, India. The company is registered under the Corporate Identification Number (CIN) U51909MH2021PTC370327. It operates in the wholesale trade and commission trade sector, excluding motor vehicles and motorcycles. The authorized and paid-up capital of the company is ₹1.5 million. The registered office is located at A3, Bonanza Industrial Estate, A C Road, Ashok Nagar, Kandivali East, Mumbai, Maharashtra, 400101.

The company's leadership comprises Piyansh Omprakash Mantry, serving as the Managing Director, and Omprakash Shankarlal Mantry, who holds the position of Director. Both directors have been associated with the company since its inception. As of the latest available data, the company has not publicly disclosed its revenue or employee count.

What Does 3S Pharmaceuticals India Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Pembrolizumab$201.7K 2

Product Portfolio — Top 10 by Export Value

3S Pharmaceuticals India Private Limited exports 10 pharmaceutical products across 3 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Pembrolizumab	Advanced Oncology	$201.7K	12	10.4%	3
2	Lenalidomide	Advanced Oncology	$88.4K	56	0.0%	14
3	Daratumumab	Advanced Oncology	$64.9K	9	4.9%	5
4	Thalidomide	Advanced Oncology	$34.7K	34	1.8%	8
5	Proguanil	Antimalarial & Antiparasitic	$29.0K	6	0.0%	9
6	Atovaquone	Antimalarial & Antiparasitic	$26.9K	5	0.0%	9
7	Pomalidomide	Advanced Oncology	$26.8K	14	0.6%	5
8	Cladribine	Advanced Oncology	$6.7K	3	2.9%	9
9	Chlorambucil	Advanced Oncology	$4.1K	10	1.2%	7
10	Etanercept	Biologics & Immunotherapy	$1.2K	3	0.0%	9

3S Pharmaceuticals India Private Limited exports 10 pharmaceutical products across 3 therapeutic categories with a total export value of $484.3K. The top category is Advanced Oncology (88.2% of portfolio), followed by Antimalarial & Antiparasitic (11.5%), indicating a concentrated portfolio with the top 5 products accounting for 86.4% of total export value.

3S Pharmaceuticals India Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

3S Pharmaceuticals India Private Limited does not own or operate any manufacturing facilities. The company functions as a wholesaler and exporter, sourcing pharmaceutical products from various manufacturers to supply to its clients.

3Key Leadership

The key leadership of 3S Pharmaceuticals India Private Limited includes:

Piyansh Omprakash Mantry: Managing Director, responsible for overseeing the company's strategic direction and operations.

Omprakash Shankarlal Mantry: Director, involved in the company's management and decision-making processes.

Both directors have been associated with the company since its incorporation on October 26, 2021.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does 3S Pharmaceuticals India Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

As of March 2026, 3S Pharmaceuticals India Private Limited has not publicly disclosed any regulatory filings, approvals, or market access statuses in the United States, European Union, United Kingdom, Australia, or Japan. The company primarily operates as a wholesaler and exporter, sourcing pharmaceutical products from various manufacturers to supply to its clients.

2Emerging Markets

3S Pharmaceuticals India Private Limited has not publicly disclosed specific information regarding its penetration into emerging markets such as Africa, Latin America, or Southeast Asia. The company primarily operates as a wholesaler and exporter, sourcing pharmaceutical products from various manufacturers to supply to its clients.

3Geographic Strategy

3S Pharmaceuticals India Private Limited's geographic strategy focuses on sourcing pharmaceutical products from a diverse network of manufacturers across over 40 countries, including India, Turkey, the United States, Canada, Europe, the United Kingdom, Bangladesh, Japan, Hong Kong, New Zealand, and Brazil. This approach enables the company to offer a wide range of pharmaceutical products to its clients.

3S Pharmaceuticals India Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

As of March 2026, 3S Pharmaceuticals India Private Limited has not publicly disclosed any FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, or inspection history. The company primarily operates as a wholesaler and exporter, sourcing pharmaceutical products from various manufacturers to supply to its clients.

2WHO & EU GMP

3S Pharmaceuticals India Private Limited is a member of the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) and is registered with the Maharashtra Food and Drug Administration (FDA) under license numbers 20-B/MZ6-23015 and 21-B/MZ6-23016. Additionally, the company is an Authorized Economic Operator (AEO-T1) certified entity and has been audited and accredited by the World Health Organization – Good Storage and Distribution Practices (WHO-GSDP) by independent EU-based auditors.

3CDSCO & Indian Regulatory

3S Pharmaceuticals India Private Limited holds manufacturing licenses from the Maharashtra Food and Drug Administration (FDA) under license numbers 20-B/MZ6-23015 and 21-B/MZ6-23016. The company is also a member of the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) and is registered with the Maharashtra FDA.

3S Pharmaceuticals India Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

3S Pharmaceuticals India Private Limited operates in a competitive landscape with several key players in the pharmaceutical wholesale and export sector. Notable competitors include:

3S Corporation: A leading stockist, exporter, and wholesaler for anti-cancer drugs and oncology medicines, with a registered and government-recognized export house status.

M S Asterisk Pharmaceuticals Pvt Ltd: Engaged in the wholesale trade of pharmaceutical products, including anti-cancer drugs and other specialty medicines.

M S Medico Remedies Pvt Ltd: Specializes in the export and wholesale distribution of a wide range of pharmaceutical products, including oncology medicines.

While 3S Pharmaceuticals India Private Limited has a diverse product portfolio, its market share and position relative to these competitors are not publicly disclosed.

2Key Differentiators

3S Pharmaceuticals India Private Limited differentiates itself through:

Buyer Due Diligence Brief — Evaluating 3S Pharmaceuticals India Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

3S Pharmaceuticals India Private Limited has established a robust network of suppliers across over 40 countries, enabling it to source a diverse range of pharmaceutical products. The company emphasizes compliance with global standards of procurement, storage, and distribution of drugs. However, specific details regarding export volume, consistency, and reliability indicators are not publicly disclosed.

2Certifications to Verify

Importers should verify the following certifications when considering 3S Pharmaceuticals India Private Limited as a supplier:

FDA Registration: Confirm the company's registration with the U.S. Food and Drug Administration (FDA) for exporting pharmaceutical products to the United States.

WHO-GMP Certification: Verify the company's compliance with the World Health Organization's Good Manufacturing Practices (GMP) standards.

Frequently Asked Questions — 3S Pharmaceuticals India Private Limited

How many pharmaceutical products does 3S Pharmaceuticals India Private Limited export from India?

3S Pharmaceuticals India Private Limited exports 10 pharmaceutical products across 3 therapeutic categories. The top exports are Pembrolizumab ($201.7K), Lenalidomide ($88.4K), Daratumumab ($64.9K), Thalidomide ($34.7K), Proguanil ($29.0K). Total export value is $484.3K.

What is 3S Pharmaceuticals India Private Limited's total pharmaceutical export value?

3S Pharmaceuticals India Private Limited's total pharmaceutical export value is $484.3K, based on 152 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does 3S Pharmaceuticals India Private Limited cover?

3S Pharmaceuticals India Private Limited exports across 3 therapeutic categories. The largest are Advanced Oncology (88.2%, 7 products), Antimalarial & Antiparasitic (11.5%, 2 products), Biologics & Immunotherapy (0.2%, 1 products).

Get Full 3S Pharmaceuticals India Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.